The largest database of trusted experimental protocols

12 protocols using chorulon

1

Xenopus Egg Extracts for Cell Cycle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eggs were collected from female Xenopus laevis frogs 16–18 hours after egg laying was induced by injection of 500 U of human chorionic gonadotropin (Chorulon from Merck, Sigma #CG10–10VL). Cytostatic factor- (CSF-) arrested and cycling extracts were prepared as described previously,89 (link) except that for cycling extracts eggs were activated with the calcium ionophore A23187 (200 ng/μL, Sigma Aldrich # C7522) rather than electric shock. CSF extracts were stored at −80°C until use; cycling extracts were used directly after preparation.
Animal work was conducted in accordance with relevant national and international guidelines and all animal protocols were approved by the Stanford University Administrative Panel on Laboratory Animal Care (APLAC protocol 13307).
+ Open protocol
+ Expand
2

Bovine Oocyte Isolation and In Vitro Maturation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bovine ovaries were obtained from a commercial slaughterhouse and transported in warm sterile saline [0.9% (w/v) NaCl] for about 3 h. In the laboratory the ovaries were washed several times again with sterile saline to remove blood and debris. Cumulus-oocyte complexes (COCs) were collected by aspiration of follicles with diameter between 2 and 8 mm using syringe and needle.
For in vitro maturation (IVM), groups of 25–30 oocytes were placed in 90 μL drops of the maturation medium (TCM-199 bicarbonate supplemented with 10% of FBS, 0.5 μg/mL FSH [Folltropin-V, Bioniche, Belleville, Canada], 100 IU/mL hCG [Chorulon, Merck Animal Health, Boxmeer, The Netherlands]) under mineral oil. Maturation of COCs followed in an incubator at 38.5 °C, 5% CO2 in air and high humidity for 24 h.
Frozen commercial semen straws from 2 bulls were thawed in a water bath at 37 °C for 30 s and their contents were mixed and centrifuged on a discontinuous Percoll gradient (45% and 90%) as a strategy to avoid the influence of the bull in the kinetics of embryo development. Sperm concentration was adjusted to 1 × 106 sperm/mL. Matured COCs were transferred to 90 μL drops of fertilization media19 (link) and covered with mineral oil. Oocytes and sperm were incubated at the same conditions of air and temperature for 18 h. This study did not require direct handling of animals.
+ Open protocol
+ Expand
3

In Vitro Maturation of Bovine COCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
When comCOCs or expCOCs were subjected to IVM, they underwent four washes in drops of HH medium without IBMX and NPPC followed by four washes in the IVM medium. The IVM medium consisted of Medium 199 supplemented with 22 µg/ml sodium pyruvate, 4 IU/ml hCG (Chorulon®; Merck & Co., Inc., Rahway, NJ, USA), 50 µg/ml gentamicin, and 100 µl/ml fetal bovine serum (Patel et al., 2007 (link)). COCs were cultured in 10 µl drops of IVM medium in groups of 3–5 for 22 h at 38.5°C in a 5% CO2 atmosphere with 100% humidity.
To assess the nuclear maturation of COCs after IVM, our statistical power analysis limited us to groups of 3–5 COCs per drop from each heifer unless otherwise specified. However, a preliminary study was conducted to aspirate COCs from ovaries collected from cattle at a local abattoir (West Michigan Beef Co LLC, Hudsonville, MI, USA) to determine if 3 or 5 COCs per drop was representative of the proportion of oocytes reaching metaphase II (MII) during IVM. Chi square analysis indicated that groups of 3 (n = 55) or 5 (n = 31) COCs per drop did indeed produce similar proportions of MII oocytes during IVM (mean ± SEM, 71 ± 2% versus 80 ± 6%, respectively, P ≥ 0.85). Data for heifers that had <3 COCs recovered by oocyte retrieval were not subjected to IVM and were omitted from statistical analysis.
+ Open protocol
+ Expand
4

Embryo Isolation and In Vitro Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four- to six-week-old female CD-1 mice received a 5–7.5 international units (IU) intraperitoneal (i.p.) injection with pregnant mare’s serum gonadotropin (Folligon, Merck Animal Health, Canada). This was followed by a 5–7.5 IU i.p. injection of human chorionic gonadotrophin (Chorulon, Merck) 46–48 h later. Following the second injection, each female was placed in a cage with a single male CD-1 mouse (3–8 months of age) for mating overnight. The following morning, female mice were checked for presence of a seminal plug. Forty-six hours post-injection of hCG, female mice were sacrificed by CO2 asphyxiation (standard operating procedure). Their oviducts were collected and flushed with M2 flushing medium (Sigma–Aldrich). Flushed two-cell stage embryos were washed 3× in 50 μL drops of potassium simplex optimization medium with amino acids (KSOMaa Evolve, Zenith Biotech, Canada) for OCT4/CDX2 and cell counting experiments. Due to discontinuation of this product, YAP, Na/K ATPase α-1, E-cadherin and ZO-1experiments were conducted with KSOM+AA (IVL04, Caisson Laboratories, Smithfield, UT). After washing, embryos were distributed equally among experimental treatment groups and cultured in 20 μL drops under mineral oil (LiteOil LGOL-500, Cooper Surgical, Trumbull, CT) at a density of 1 embryo per μL for 46 h under a 5% CO2,5% O2 and 90% N2culture atmosphere.
+ Open protocol
+ Expand
5

CRISPR Zygote Microinjection in Swine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripuberal gilts (100 kg BW) were injected with PG 600® (400 IU pregnant mare’s serum gonadotropin and 200 IU human chorionic gonadotropin per dose, Merck, Kenilworth, NJ) followed by Chorulon® (750 IU human chorionic gonadotropin per dose, Merck) to induce timed ovulation. Females were inseminated 30 h after Chorulon® injection and embryos recovered 48 h after Chorulon® injection. Zygotes were microinjected with Cas9 protein and gRNA or combination of gRNAs via cytoplasmic microinjection 9 to 10 h post-fertilization. Any embryos that divided before microinjection were discarded. Guide RNAs were diluted to a final concentration of 25 ng/μL and the concentration of the Cas9 protein was 50 ng/μL. When a combination of gRNAs was microinjected into zygotes, their combined final concentration was also 25 ng/μL.
+ Open protocol
+ Expand
6

Xenopus Egg Extracts for Cell Cycle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eggs were collected from female Xenopus laevis frogs 16–18 hours after egg laying was induced by injection of 500 U of human chorionic gonadotropin (Chorulon from Merck, Sigma #CG10–10VL). Cytostatic factor- (CSF-) arrested and cycling extracts were prepared as described previously,89 (link) except that for cycling extracts eggs were activated with the calcium ionophore A23187 (200 ng/μL, Sigma Aldrich # C7522) rather than electric shock. CSF extracts were stored at −80°C until use; cycling extracts were used directly after preparation.
Animal work was conducted in accordance with relevant national and international guidelines and all animal protocols were approved by the Stanford University Administrative Panel on Laboratory Animal Care (APLAC protocol 13307).
+ Open protocol
+ Expand
7

Superovulation and Embryo Collection in Cattle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prostaglandin F (PGF; Lutalyse) was from Zoetis (New York, NY, USA). The hCG (chorionic gonadotropin, 3300 IU/dose; Chorulon) was from Merck Animal Health (Milsboro, DE, USA). The pituitary-derived FSH (NIH-FSH-P; Folltropin-V) from a single batch was from Bioniche Animal Health Canada Inc. (Belleville, Ontario, Canada). The experimental LArbFSH types A and B were provided by CEVA Animal Health. Intravaginal progesterone (P4) devices (Eazi-Breed CIDR; containing 1.38 g of progesterone) were from Zoetis (New York, NY, USA). Lidocaine (Lidocaine Hydrochloride Injectable 2%; 3 mL/dose) was from Phoenix Pharmaceutical Inc. (St. Joseph, MO, USA). Embryo filters (MiniFlush Embryo System) and y-tubing (Y-Junction Tubing) were from Minitube of America Inc. (Verona, WI, USA). Catheters (Silicon ET catheter CH16, 2-way Foley, 5 mL balloon) and embryo collection medium (BioLife Advantage Embryo Collection Medium, 2 L) were from Agtech, Inc. (Manhattan, KS, USA). Holding medium (Vigro Holding Plus) was from Bioniche Animal Health Canada Inc. (Pullman, WA, USA). All inseminations were performed using conventional frozen semen (20 × 106 sperm per straw) from three Holstein sires with high genetic merit from two AI companies. All AI sires had proven outstanding field fertility and were equally balanced among treatments.
+ Open protocol
+ Expand
8

Impact of hCG Timing on Ovulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Day of ovulation was considered the most critical point of measurement for calculation of time of fertilization due to the short lifespan of the oocyte (Szollosi, 1973; Hunter, 1985) . Therefore, all outcomes in this study are related to days postovulation. Day of ovulation was calculated as 24 to 32 h (Pursley et al., 1995) (link) after final GnRH of Double-Ovsynch or Ovsynch-56.
Cows with functional CL and at least one large (≥10 mm) follicle on the day of PGF 2α 56 h before final GnRH of Double-Ovsynch or Ovsynch-56 were considered synchronized. The CL function was determined by the presence of blood flow through the entire tissue of each CL via color Doppler. Only synchronized cows were randomized in blocks by service and parity and assigned into one of 4 treatments: 3,000 IU of hCG (Chorulon, Merck Animal Health) on d 2 postovulation (D2), 3,000 IU of hCG on d 2 and 5 postovulation (D2+5), 3,000 IU of hCG on d 5 postovulation (D5), and no treatment (control; Figure 1).
Administrations of PGF 2α , GnRH, and hCG were performed in either the semitendinosus or semimembranosus muscles using 3.5-cm, 20-gauge, single-use needles, and 3-mL, single-use syringes (Becton, Dickinson and Co.).
+ Open protocol
+ Expand
9

Bovine Oocyte Maturation in Vitro

Check if the same lab product or an alternative is used in the 5 most similar protocols
After grading and selection, usable COCs were placed into 50 μL drops of maturation media under mineral oil (Fisher Scientific, Ottawa, ON, Canada) in groups of around 10 after being washed. Maturation media consisted of TCM-199, 100 μg/mL cysteine, 5 UI/mL hCG (Chorulon®; Merck Animal Health, Kirkland, QC, Canada), 10 μg/mL FSH (Folltropin-V®), 1 μg/mL 17 β Estradiol, 0.2 mM pyruvate, 2 mM L-carnitine, 5 μL/mL insulin-transferrin-selenium (ITS), 3 μL/mL stock FLI, 10 ng/mL epidermal growth factor (EGF; Life Technologies), 50 μg/mL gentamicin, 10% v/v fetal bovine serum (FBS). Stock FLI contained 20 ng/mL recombinant human leukemia inhibitory factor (LIF; Peprotech, Cranbury, NJ, USA), 20 ng/mL recombinant human insulin-like growth factor 1 (IGF1; Peprotech) and 40 ng/mL recombinant human fibroblast growth factor 2 (FGF2; Gold Biotechnology, St. Louis, MO, USA). COCs were incubated at 38.5 °C in 5% CO2 and 95% air for around 24 h.
+ Open protocol
+ Expand
10

Synchronization and hCG Treatments in Dairy Cows

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cows between 39 and 64 DIM (mean ± SD = 45.2 ± 6.0) were submitted to a pretreatment for synchronization of ovulation, consisting of an Ovsynch + controlled internal drug-release insert (CIDR; Figure 1; Pursley et al., 1995) (link). Briefly, cows received GnRH (200 µg i.m.; Factrel, Zoetis) and a P4 intravaginal insert (Eazi-Breed CIDR; Zoetis). Seven days later, the P4 insert was removed, and prostaglandin F 2α (PGF 2α 25 mg i.m.; Lutalyse HighCon, Zoetis) was administered, followed by another PGF 2α 1 d later and a second GnRH 1 d after the second PGF 2α . Only synchronized cows with complete CL regression 2 d after PGF 2α (serum P4 < 1.0 ng/mL) and ovulation by 2 d after the last GnRH were used in the study (n = 64). The last GnRH of pretreatment was considered d 0 of the estrous cycle. After confirmation of synchronization, cows were randomly assigned to one of 3 treatments. Control cows (n = 22) did not receive any treatment except the synchronization protocol. Cows enrolled in the second treatment group (hCG7; n = 20) received an i.m. treatment with 3,300 IU of hCG (Chorulon, Merck Animal Health) 7 d after the last GnRH (d 7 of the cycle), and cows enrolled in the third treatment group (hCG7+13; n = 22) received 2 hCG treatments with 3,300 IU, one on d 7 and a second on d 13 after the last GnRH (d 7 and d 13 of the estrous cycle).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!